A simple reverse-phase liquid chromatographic method has been developed for the quantitative measurement of 11 3a-OH bile acids in paediatric serum samples. Bile acids are enzymatically reduced to the corresponding 3-keto compound and then derivatized with the fluorophore dansyl hydrazine. Preliminary fractionation of bile acids is not required. The limit of detection is O' 1 ILmol/L using a sample size of 200 ILL. One hundred and twenty-three serum samples were analysed by the highperformance liquid chromatography (HPLC) method and the results compared with a commercial kit method (Enzabile) presently used in many laboratories for the measurement of total bile acids. There was a good correlation between the two methods (1'=0,96). The method is suitable for use in a clinical laboratory for the further investigation of those patients with abnormally high total bile acid levels where quantification of bile acid fractions is required.
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The measurement of total serum bile acids has been performed over the last decade as a sensitive indicator of liver dysfunction.t-' With the advent of more sophisticated techniques it is now possible to measure individual bile acids, and assess their diagnostic value in the detection and management of liver disease.
Many methods have been used for the determination of individual bile acids in serum. Most have required a preliminary fractionation of bile acids into glycine, taurine and unconjugated groups by the use of Sephadex LH-20 cartridges with subsequent measurement of bile acids by gas chromatography-mass spectrometry (GC-MS)3,4 or high performance liquid chromatography (HPLC) with either UV absorption'-" or fluorescence detection.l? With the introduction of an immobilized enzyme column in 1979 10 the simultaneous measurement of conjugated and unconjugated bile acids without prior fractionation was developed. However, immobilized enzyme columns are of questionable value with some workers using them Correspondence: Mrs R F Goldsmith. as a qualitative technique only with a further system needed for quantitative analysis.'! We have developed a simple technique for the quantitative separation of 11 bile acids in serum involving the conversion of 3a-OH bile acids to 3-keto compounds with the enzyme 3a-OH steroid dehydrogenase followed by derivatization of the keto bile acids with the fluorophore dansyl hydrazine. Preliminary fractionation is not required. This method has been used with bile samples" but has not previously been applied to serum.
MATERIALS AND METHODS
Instrumentation A Spectraphysics HPLC system consisting of a SP8800 gradient pump, SP8880 autosampler and SP4400 integrator attached to a variable wavelength spectrofluorometer (Jasco FP110D, Jasco Int. Co. Ltd) equipped with a xenon lamp were used. Excitation wavelength was maintained at 360nm and emission at 51Onm.
Separation was achieved on a Brownlee Spheri-5 ODS 5 IL column, 25 em x 4·6 mm (Applied Biosystems, Foster City, CA, USA) with a RP-18 pre column attached (7-p.m particles, 'Newguard'; Applied Biosystems).
Reagents

Standards
Free acid forms of cholic acid (C), chenodeoxycholic acid (CDC), deoxycholic acid (DC), lithocholic acid (LC), glycocholic acid (GC), glycochenodeoxycholic acid (GCDC), glycodeoxycholic acid (GDC), glycolithocholic acid (GLC) and sodium salts of taurocholic acid (TC), taurochenodeoxycholic acid (TCDC), taurodeoxycholic acid (TDC) and taurolithocholic acid (TLC) were purchased from Sigma Chem Co. (St Louis, MO, USA) and prepared as 20 mmol/L stock solutions in methanol for free and glyco-bile acids and in 50070 methanol-water for tauro-bile acids. These were diluted to 200 p.mol/L solutions for use as working standards. Internal standard. Lithocholic acid (100 p.mol/L methanol) was used as internal standard.
Other reagents NAD+, 3a-OH steroid dehydrogenase, tetrabutylammonium phosphate and dansyl hydrazine were from Sigma Chem Co. (St Louis, MO, USA). Methanol and acetonitrile were HPLC grade (Mallinckrodt Australia Pty Ltd). All other reagents were analytical grade or higher.
C18 cartridges were 100 mg Bond Elut cartridges (Analytical International, CA, USA) and were used with a Vac Elut system (Analytical International, CA, USA) which holds 10 cartridges.
Reagent solutions
Fifty millimolar pH 9'5 phosphate buffertetrasodium pyrophosphate was brought to pH 9·5 with phosphoric acid and adjusted to a fmal concentration of 50 mmol/L. 3a-OH steroid dehydrogenase was used as a 20 U/L solution in 50 mmol/L pH 9· 5 phosphate buffer.
NAD + was used as a 10 mmol/L solution in pH 9· 5 phosphate buffer. Dansyl hydrazine was prepared as a 20 mg/mL solution in 50: 50 acetonitrile: methanol. Immediately before use 0·8 M KOH was added (final concentration 0·08 mol/L; 100 p.L O' 8 M KOH/ml dansyl reagent).
Tetrabutylammonium phosphate (TBAP) was prepared as a 20% solution in water and adjusted to pH 3·6 with phosphoric acid.
Acid methanol: 10 p.L concentrated HCI and 400 p.L water were added to 10 mL methanol.
Ann Clin Biochem 1994: 31
Chromatographic conditions All HPLC solvents were filtered through O' 45 p.m (pore size) filters and degassed with helium during use. Stock buffer was 2 mol/L sodium dihydrogen phosphate. A working buffer was prepared each day consisting of 5 mL stock buffer and 200 p.L TBAP diluted to 1 L with water and adjusted to pH 3'6 with 25% phosphoric acid.
Buffer A was working buffer/methanol/ acetonitrile/water (50: 45: I . 25: 3 . 75). Buffer B was methanol/acetonitrile/water (90: 2' 5: 7,5) to which was added 200 p.L TBAP/L of buffer.
The following gradient system was used: zero time 20% B, increased to 30% B at 10 min, 45% B at 20 min, held at 45% B for 5 min then increased to 90% B at 55 min, 98% B at 60 min and held at 98% for 2 min. Requilibration to 20% B was achieved over 3 min and the system was left a further 5 min before the next injection. The flow rate was 1· 0 mL/min.
Procedure
Principle of method ( Fig. 1 ) Bile acids are converted to keto acids by enzyme reaction with 3a-OH steroid dehydrogenase. Keto bile acids are then heated in alkali to free the bile acids bound to protein and lipoprotein micelles. The bile acids are extracted using Bond-Elut Cl8 columns. Finally, keto bile acids are derivatized with the fluorescent agent dansyl hydrazine to form highly fluorescent derivatives which are separated and measured by HPLC. Serum samples were processed in duplicate. Enzyme was withheld from one of the two samples which then constituted a blank sample to check for the presence of endogenous keto compounds in the serum samples. Both the enzyme reaction and the blank reaction were allowed to proceed for 15 min at 37°C.
One hundred and fifty microlitres O' 8 mol/L KOH was added (final concentration O' 2 mol/L KOH) to each of the tubes which were then heated o COOH .. FIGURE 1. Principle of method for bile acid analysis involving enzyme hydrolysis with 3a.OH-steroid dehydrogenase followed by derivatization with dansyl hydrazine.
at 75°C for 5-10 min. The contents of the tubes were applied, while hot, to Bond-Elut-CI8 cartridges previously washed with 5 mL MeOH and 5 mL water. The cartridges were immediately washed five times with 1 mL of water and the bile acids eluted into autosampler vials with 300 ILL acid methanol.
After overnight refrigeration at 7°C 25 ILL dansyl hydrazine reagent was added, the vials were heated at 6Q°C for 10 min to allow reaction to take place. Twenty microlitres was used for injection.
Total bile acid analysis
Total bile acid concentrations were measured with the Enzabile commercial kit (Nycomed, Oslo, Norway) on a Cobas Mira autoanalyser using a standard protocol of a blank and test reading for each sample. Samples containing bile acids at concentrations> 100 ",mollL were diluted with saline and reanalysed. Figure 2 shows a chromatogram of; (a) a standard mixture of 11 bile acids in serum; and (b) a patient serum containing 23 ILmollL of total bile acids. All the major bile acids were separated on our system except for the free bile acids CDC and DC which co-eluted. Bile acid peaks were well separated from reagent peaks which were present at the beginning of the run. Peak heights for the standard bile acids were approximately of equal height indicating similar extraction and derivatization characteristics of the monohydroxy (LC), dihydroxy (CDC) and trihydroxy (cholate) bile acids.
RESULTS
Chromatography
Assay evaluation Linearity
Linearity was determined by preparing spiked bovine serum albumin samples containing 0,25, 0'5,1,2,5,10,20,40 and 50ILmollL of each bile acid and subjecting the data to linear regression analysis. The linearity of the method was limited by enzyme saturation of the 3a-OH steroid dehydrogenase enzyme in the first step of the method. This enzyme was only linear to a total bile acid concentration of 220 ",mol/L. Thus for the standard mixture which contained 11 bile acids each bile acid was linear from a concentration of O·25 to 20 ILmollL. All samples containing bile acids > 200 ILmollL for the HPLC method were diluted with bovine serum albumin and reanalysed.
For each bile acid there was good linear correlation between concentration and peak height ratios of bile acid to internal standard over a range of O·25 to 20 ILmollL. The correlation coefficients were (r) all >0·98. The mean slope was O· 10 ±O' 02 ranging from O· 08 for taurochenodeoxycholate to 0·15 for cholate.
The limit of detection (signal to noise > 3) was O· I ILmollL using a sample size of 200 ",L (equivalent to 1· 2 pmole injected).
Recovery
Recovery studies were performed by analysing serum samples to which either 4 or 20 ",mollL of each bile acid had been added. Percentage recovery was calculated as (amount recovered/ amount added) x 100. Recovery of the bile acids over eight assay runs averaged 103· 6OJo and 95' 3% for the 4 and 20 ILmollL samples, respectively (Table 1 ). There was no significant difference between recoveries of mono, di and trihydroxy bile acids as might be expected if extraction rates were varying relative to the internal standard (LC).
Reproducibility
Reproducibility was carried out by analysing bovine serum albumin samples containing 5, 10 and 20 JLmol/L of each bile acid and a pooled serum sample in eight consecutive runs over a period of 8 weeks. Coefficients of variation (relative to internal standard) ranged from 1. 9070 to 8·2% for the standard samples and 8·5% to 20'0% for the pooled serum (Table 1) . These values represent variation due to the enzyme reaction, column extraction of bile acids and derivatization and chromatography. In the pooled serum the higher CVs were associated Ann Clin Biochem 1994: 31 with very low concentrations of C and CDC/DC present in the sample.
Interference
The extremely low concentrations of bile acids present in serum necessitatesan assay methodology capable of providing rigorous exclusion of interfering compounds. Confidence in identification of small bile acid peaks was achieved by having a blank for each patient sample which was the same sample to which no enzyme was added (Fig. 2bbottom trace) . This was run immediately before the enzyme hydrolysed sample and thus enabled proper identification of bile acid from background peaks. This proved very successful with chromatography being optimized to separate the bile acids from interfering peaks. In caseswhere this was not possible baseline subtraction was utilized.
Correlation with total bile acid method
One hundred and twenty-three serum samples were analysed by both the HPLC method and the Enzabile test kit with the concentration of total bile acids ranging from 0'5 to 71 JLmol/L. There was a good correlation between the sum of individual bile acids by HPLC method and total bile acids by the Enzabile method (r= 0'958; HPLC = O' 91 Enzabile + O· 346). Agreement between the two methods was assessed using Oldham's plot" in which the difference between the two methods is plotted against the mean of the two values ( Fig. 3 ). There is no clear evidence of a relationship between difference and mean value (r= -0'201, P=0·05). There is little evidence of an overall bias, the mean difference (Enzabile -HPLC) being O' 70, with a standard deviation of 3· 75 and the 95% confidence interval for the bias being 0·36 to 1· 03 JLmol/L. On the basis of these data we conclude the two methods are comparable. Samples over 100 JLmol/L were analysed separately with HPLC levels having a tendency to be higher than Enzabile values (HPLC totals of 122, 144, 172, 211, 438, 493 and 600 JLmol/L corresponding to Enzabile totals of 79, 102, 158, 145, 380, 330, 537 JLmol/L, respectively). Serum samples with high levels of bile acids often had very high blank values when determined by the Enzabile method and this may have contributed to a falsely low test level in these samples.
DISCUSSION
Measurement of bile acids by gas-liquid chromatography (OLC), with or without Bile acids in serum have been measured previously by a method similar to ours.!" However this method uses an immobilized enzyme column for reaction rather than the simpler test tube hydrolysis we have used and prior fractionation of samples into tauro, glyco and free forms was also necessary. Thus, our method is one of the simpler methods currently available for the measurement of free and conjugated bile acids in serum and is therefore suited to any clinical laboratory currently using HPLC techniques. Enzyme reaction and extraction of 20-30 samples can be achieved in less than 2· 50 h, no drying down steps are necessary and only one cartridge clean up step is utilized. Optimum conditions are used for the release of bile acids from bound forms (dilution, alkalinization above pH 12 and heat). 15 Surface functional groups on CI8 cartridges are susceptible to deterioration with sustained alkaline conditions. So after application of the heated alkaline samples the cartridges are immediately washed with water, to ensure complete removal of alkali. Preliminary experiments showed that only 300 iLL of acid methanol was necessary to extract > 99% of bile acids from the Bond Elut cartridges. The best conditions for the dansyl reaction are the result of a compromise." The keto bile acids must be in the protonated form for optimum reaction while the dansyl hydrazine reagent needs to be present as free base and o o detection by mass spectrometry (GC-MS), has been the mainstay of methods employed for serum bile acid analysis. However, GC-MS is not a suitable technique for the direct measurement of glycine and taurine conjugated bile acids as samples have to be fractionated and hydrolysed to free forms before measurement. Most HPLC methods currently employed also use this same group fractionation of bile acids and as a result quantitation is often reported as total deoxycholic, cholic and chenodeoxycholic groups with no further breakdown into glycine and taurine fractions. therefore capable of nucleophilic attack (Fig. 1 ). This was achieved in our method by eluting the bile acids from Bond Elut columns with acid methanol to ensure protonation and adding potassium hydroxide to the dansyl hydrazine reagent just before the derivatization reaction to ensure its presence as free base.
Analysis by Oldham's plot showed there is good agreement between our HPLC method and the Enzabile method commonly used for the measurement of total serum bile acids in many clinical laboratories. More work needs to be done to determine the reason for the apparent higher HPLC values in those few patients having total serum bile acids greater than 100 ILmol/L. Although many methods have been published for the determination of bile acids in physiological fluids there is a dearth of knowledge on the agreement or otherwise between the different methods. Indeed many published methods report only per cent concentrations of conjugate analytes rather than actual concentrations, consequently there are few established reference intervals for conjugated bile acids in serum.
One disadvantage of our technique is that free CDC and DC are not separated on our system under the chromatographic conditions employed. However they can be separated on a separate system by removing a small portion of the methanol extract (10 ILL) and reacting it with 4-bromomethyl 7-methoxycoumarin (BMC).17 Ursodeoxycholic acid and its conjugates can be identified on our system but were not measured as they were found to give very broad peak shapes making quantitation difficult.
We have developed a relatively simple HPLC method for the routine determination of bile acids in serum. This method is currently being used to establish reference intervals in control subjects and to investigate changes in bile acid patterns in children with cystic fibrosis and liver disease, and before and after liver transplantations.
